STAAR Surgical (STAA) Stock Price, News & Analysis

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View STAA analyst ratings or view top-rated stocks.

10 Wall Street research analysts have issued 12 month price objectives for STAAR Surgical's shares. Their STAA share price targets range from $33.00 to $57.00. On average, they anticipate the company's share price to reach $46.38 in the next year. This suggests a possible upside of 0.1% from the stock's current price.
View analysts price targets for STAA or view top-rated stocks among Wall Street analysts.

STAAR Surgical's stock was trading at $31.21 at the beginning of 2024. Since then, STAA shares have increased by 48.5% and is now trading at $46.34.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our STAA earnings forecast.

STAAR Surgical (NASDAQ:STAA) released its quarterly earnings results on Monday, February, 26th. The medical instruments supplier reported $0.16 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by $0.01. The medical instruments supplier earned $76.27 million during the quarter, compared to the consensus estimate of $75.94 million. STAAR Surgical had a net margin of 6.62% and a trailing twelve-month return on equity of 8.73%. The business's revenue for the quarter was up 19.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.04 EPS.

ETFs with the largest weight of STAAR Surgical (NASDAQ:STAA) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Janus Henderson Small Cap Growth Alpha ETF (JSML), Invesco S&P SmallCap Health Care ETF (PSCH), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Principal U.S. Small-Cap Multi-Factor ETF (PSC) and Janus Henderson US Sustainable Equity ETF (SSPX).iShares U.S. Medical Devices ETF (IHI).

STAAR Surgical issued an update on its FY 2024 earnings guidance on Wednesday, April, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $340.0 million-$340.0 million, compared to the consensus revenue estimate of $337.2 million.

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

STAAR Surgical's stock is owned by a number of institutional and retail investors. Top institutional investors include APEIRON CAPITAL Ltd (0.72%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include Aimee S Weisner, Broadwood Partners, LP, Caren L Mason, Elizabeth Yeu Lin, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.